SRK-015

· Scholar Rock, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SRK-015, covering 2022-11-17 to 2022-11-17. Get the full timeline:

Most recent: Clinical Trial Update: An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy [Phase 2]